🇺🇸 FDA
Patent

US 8865883

Multiple exon skipping compositions for DMD

granted A61PA61P21/00A61P21/04

Quick answer

US patent 8865883 (Multiple exon skipping compositions for DMD) held by Sarepta Therapeutics, Inc. expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P21/00, A61P21/04